Sandoz Tells Justices Amgen Ruling 'Guts' Patent System
By Andrew Karpan ( February 12, 2021, 9:07 PM EST) -- Sandoz Inc. told the U.S. Supreme Court that the Federal Circuit upended 200 years of precedent in a ruling last year allowing Amgen and its unit Immunex Corp. to "buy themselves an exemption" from patent law to stifle competition against its billion-dollar autoimmune drug Enbrel....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.